156 Stories, most recent news story added Wed Nov 25, 11:24 am ET
Hanoi - A 23-year-old man has died of avian influenza, bringing Vietnam's bird-flu death toll to five this year, health officials said Tuesday, also confirming two more deaths from swine flu. The Ministry of Health reported the man, from the north-we...
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Reportlinker.com announces that a new market research report is available in its catalogue:
HOLLY SPRINGS, N.C. -(Dow Jones)- Swiss drug maker Novartis AG (NVS, NOVN.VX) opened a vaccine-manufacturing plant Tuesday designed to make influenza vaccines without relying on decades-old technology that employs millions of chicken eggs to grow viruses.
Nov 24, 2009 (CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes.
Cover your sneezes. Stay home if you are sick. Wash those hands. -- read more
Swine flu circulation in Oklahoma may have hit its peak — at least for now, health officials say.
LOMA LINDA - If there's a lesson to be learned from the H1N1 influenza virus, it is that the nation's vaccine production must be modernized, a top public-health official said here Monday.
Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 8 a.m.
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say. The researchers linked many powerful computer systems together to analyze enormous amounts of genetic data collected from all publicly available isolated strains of the H5N1 ...
WORCESTER, Mass. -- Generex Biotechnology Corporation announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. , Generex's wholly-owned immunotherapeutics subsidiary, made a presentation on the Company's H1N1 Swine Flu program at a national symposium on influenza.
WEST HAVEN, Conn.----NanoViricides, Inc. , announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC .
FDA backs off on Gulf Coast oyster safety plan In response to protests from the oyster industry and politicians, the Food and Drug Administration (FDA) recently announced the suspension, pending further study, of a plan to prevent the summertime contamination of Gulf Coast oysters by Vibrio vulnificus bacteria.
SAN DIEGO----Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.
Vaccine-maker Novavax said Friday it plans to sell 6.8 million shares of its stock.
